Evidence map›Paper›PMID 31773020›Full record

ReviewInternational journal of particle therapy2018

Molecular Signaling in Response to Charged Particle Exposures and its Importance in Particle Therapy.

Christine E Hellweg, Arif Ali Chishti, Sebastian Diegeler, Luis F Spitta, Bernd Henschenmacher, Christa Baumstark-Khan

Open access · diamondAbstract readReview
In one paragraph

Review in International journal of particle therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Christine E HellwegGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Arif Ali ChishtiGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Sebastian DiegelerGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Luis F SpittaGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Bernd HenschenmacherGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Christa Baumstark-KhanGerman Aerospace Center (DLR), Institute of Aerospace Medicine, Radiation Biology Department, Köln, Germany.
Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR) · DEUniversity of Karachi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Energetic, charged particles elicit an orchestrated DNA damage response (DDR) during their traversal through healthy tissues and tumors. Complex DNA damage formation, after exposure to high linear energy transfer (LET) charged particles, results in DNA repair foci formation, which begins within seconds. More protein modifications occur after high-LET, compared with low-LET, irradiation. Charged-particle exposure activates several transcription factors that are cytoprotective or cytodestructive, or that upregulate cytokine and chemokine expression, and are involved in bystander signaling. Molecular signaling for a survival or death decision in different tumor types and healthy tissues should be studied as prerequisite for shaping sensitizing and protective strategies. Long-term signaling and gene expression changes were found in various tissues of animals exposed to charged particles, and elucidation of their role in chronic and late effects of charged-particle therapy will help to develop effective preventive measures.

Indexed as

bystander effectDNA damage responseDNA repair focilinear energy transfernuclear factor κB

Identifiers

PMID31773020
PMCPMC6871585
OpenAlexW2890123113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.